SEC Form 4 · accession 0001415889-15-000112
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shepard M Goldberg
Director
Period of report
Jan 7, 2015
Accepted (ET)
Jan 12, 2015 · 9:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $1.62 | Jan 7, 2015 | A | 150,000 | A | — | Jan 7, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F125% of the options vest immediately and 25% vest at the beginning of each quarter.
- F2These options shall become exercisable after the average closing price per share of the Company's common stock for the ten (10) days prior to exercise, equals or exceeds $7.50 per share.